Related Experiment Video
Updated: Jun 28, 2026
09:40
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
TROP2 expression as prognostic marker for gastric carcinoma
G Mühlmann1, G Spizzo, J Gostner
1Center of Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Austria. gilbert.muehlmann@i-med.ac.at
Journal of Clinical Pathology
|October 22, 2008
Summary
TROP2 overexpression predicts disease recurrence in intestinal-type gastric cancer. This finding highlights TROP2 as a potential therapeutic target for high-risk patients, improving gastric cancer prognosis.
Area of Science:
- Oncology
- Cancer Biomarkers
- Gastrointestinal Oncology
Background:
- Gastric cancer recurrence rates remain high despite aggressive treatments.
- There is a critical need for biomarkers to identify patients who may benefit from further therapies.
- Tumor TROP2 expression is linked to aggressive tumors and poor outcomes in various cancers.
Purpose of the Study:
- To assess TROP2 expression in gastric cancer.
- To correlate TROP2 expression with patient characteristics and survival outcomes.
Main Methods:
- Immunohistochemistry was used to evaluate TROP2 expression in 104 gastric cancer specimens.
- Univariate and multivariate Cox regression analyses identified prognostic factors.
Main Results:
- TROP2 was overexpressed in 56% of gastric tumors, notably in intestinal-type carcinomas.
- TROP2 overexpression correlated with shorter disease-free survival in intestinal-type gastric cancer.
- TROP2 predicted poor survival in lymph node-positive patients and was an independent prognostic marker for disease-free survival in intestinal-type gastric cancer.
Conclusions:
- TROP2 serves as an independent prognostic marker for disease recurrence in intestinal-type gastric cancer.
- The widespread expression of TROP2 suggests its potential as a therapeutic target for specific gastric cancer patient groups.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...